Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Geron Corporation
Incyte Corporation
PharmaEssentia
Cellenkos, Inc.